This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet when COVID-19 – the greatest health emergency in a century – devastated the world, the Siracusa Principles seemed unequal to the task – too narrow, including with their remit limited to civil and political rights, not sufficiently specific, and above all, without sufficient accountability.
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Publichealth emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.
By Rossella De Falco Strong, well-coordinated and resilient publichealth care services play a vital role in preventing and responding to publichealth crises. What are, however, the specific legal and ethical implications of involving private actors in health care vis-à-vis publichealth emergencies?
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Indeed, as made public, the U.S. Moderna has since made over $30 billion in COVID-19 vaccine sales. By Aparajita Lath.
While receiving significant global traction and acceptance since their publication in 1985, the Siracusa Principles, the authors argue, proved to be simply “unequal to the task” of guiding States’ conduct in the context of COVID-19 because they are “unable to speak in any significant detail to the particular concerns of publichealth crises.”
The COVID-19 pandemic has highlighted the pervasive inequities experienced by historically marginalized communities, including people with disabilities. Although disabled people have always experienced inequities concerning economic security, these disparities have grown substantially throughout the COVID-19 pandemic.
Despite these experiences, Kenya failed take a human rights-based approach to responding to COVID-19, as was also the case in many other countries. Deepening this challenge, the enactment of new legislation during the COVID-19 pandemic — and especially in its early stages — was near impossible.
By Anita Gholami The Parliamentary Assembly of the Council of Europe, which brings together parliamentarians from 46 member States, has been a vigilant guardian of respect for the European Convention on Human Rights and other international standards throughout the COVID-19 pandemic.
By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of publichealth crises are once again rapidly fading from view.
By Calvin Wai-Loon Ho With the mainstreaming of digital technology across many spheres of social life, infodemic management must be an integral part of publichealth emergency prevention, preparedness, response, and recovery.
By Zione Ntaba Malawi is not a stranger to publichealth crises in the last number of years, having faced a severe HIV epidemic and several cholera outbreaks continuing into 2023. Nevertheless, the onset of the COVID-19 pandemic caused a major panic in the country’s legal system and judiciary.
By Sheila Varadan, Ton Liefaard, and Jaap Doek The Principles and Guidelines on Human Rights and PublicHealth Emergencies (Principles) make a significant contribution towards clarifying the scope of States’ legal obligations under international human rights law during publichealth emergencies.
By Anne Kjersti Befring and Cecilia Marcela Bailliet Introduction The COVID-19 pandemic posed a grave threat to humanity and revealed the need for a new approach to improve transnational cooperation within the global health system and new perspectives on solidarity addressing the cross-border spread of infection and distribution of vaccines.
The COVID-19 pandemic has raised unprecedented challenges for the global health framework and its long-term consequences are not yet in full sight. The alarm mechanism based on the declaration of PublicHealth Emergency of International Concern (PHEIC), in particular, has been severely tested.
Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. However, some suggest that patents are impeding access to research.
Like plaintiffs with other conditions lacking definitive physiological markers, long COVID plaintiffs seeking disability anti-discrimination law protections have confronted courts suspicious of their reports of symptoms and insistent on medical evidence in order for them to qualify as “disabled” and entitled to statutory protection.
In a publichealth emergency, pharmaceutical manufacturers’ liability concerns can slow the deployment of urgently needed vaccines and other medical countermeasures (MCMs). Products used during publichealth emergencies raise unique issues either because of their novelty, scale and type of proposed use, or regulatory pathway.
To design systems and policies that promote the right to health, a holistic and proactive approach is needed, one in which people, institutions, and corporations have a shared responsibility in promoting physical, mental, and social well-being. health care system. COVID-19 and the U.S.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. Impact of the judgment: what have records disclosed shown?
By Silvia Serrano Guzmán On July 4, 2023 the Constitutional Court of Colombia handed down a landmark decision on one of the most difficult dilemmas faced during the COVID-19 pandemic: the rationing of intensive care in situations of scarcity. The Colombian case reinforces that human rights and publichealth are not mutually exclusive.
In the Relevance Quotient methodology, W2O Group defines key stakeholders as employees, patients (including the sick and the well, caregivers, consumers, et al), health care providers, advocacy groups, analysts and investors, policy makers, journalists and media outlets. This includes health care.
however, contend that these rulings have little import today, as more recent jurisprudence gives the federal government power to regulate health care. As proof, they cite three cases: the Court’s 2005 ruling in Gonzales v. Marino et al., Oregon , and NFIB v.
A novel coronavirus, now called SARS-CoV-19, was first detected in the Hubei province of China in early December 2019. Travel is being restricted, large scale public events are likely to be cancelled, and schools and businesses may be closed to contain the spread of the virus. There is now an FDA policy released on 29 Feb.
The rules of RDC 786/2023correspond to a normative update, which replaces RDC 302/2005. Experience with large-scale events such as Hurricane Maria and the COVID-19 pandemic, and more recent geopolitical events, have cast a wider lens on global supply chain and distribution vulnerabilities.
The rules of RDC 786/2023 correspond to a normative update, which replaces RDC 302/2005. The new resolution applies to health establishments classified as laboratories and services that perform activities related to clinical analysis examinations.
lá rightly characterizes as the slipperiness of both the terms “decolonizing” and “global health,” these calls speak to the need to reimagine governance structures, knowledge discourses, and legal frameworks — from intellectual property to international financial regulation.
Despite pediatric COVID-19 vaccine availability, many youth remain unvaccinated , and are thus at higher risk of life-altering outcomes as a result of contracting COVID-19. [1]. Youth in the foster care system and those who are justice-involved face additional challenges during the ongoing COVID-19 pandemic.
health care system that existed before the publichealth crisis. What lessons can be learned from the COVID-19 stress-test to build American health care back better? health system, including 637 health systems, two-thirds of which are not-for-profit and most operating in one state.
By María Natalia Echegoyemberry and Francisco Verbic This article looks at the COVID-19 pandemic response in Argentina, with a particular focus on the judicial control of publichealth policies. There, too, single judges decided on important social and health issues. The case has parallels to rulings in the U.S.
So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 247d(a), 247d-6d(a)(1). 247d-6d(a)(2)(A)(i).
We scratched our heads last year when the Third Circuit misconstrued the federal PREP Act to allow a state-law negligence claim arising from an alleged COVID-related death, in direct contravention of the Act’s express preemption. July 19, 2022). . See Maglioli v. Alliance HC Holdings LLC , 16 F. 4th 393 (3d Cir. LEXIS 127474 (E.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content